157 related articles for article (PubMed ID: 36774339)
1. DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.
Ye D; Wang Y; Deng X; Zhou X; Liu D; Zhou B; Zheng W; Wang X; Fang L
Cell Death Dis; 2023 Feb; 14(2):106. PubMed ID: 36774339
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling.
Fu Y; Feng MX; Yu J; Ma MZ; Liu XJ; Li J; Yang XM; Wang YH; Zhang YL; Ao JP; Xue F; Qin W; Gu J; Xia Q; Zhang ZG
Oncotarget; 2014 Aug; 5(16):6701-15. PubMed ID: 25149533
[TBL] [Abstract][Full Text] [Related]
3. Dermatopontin: a potential predictor for metastasis of human oral cancer.
Yamatoji M; Kasamatsu A; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Int J Cancer; 2012 Jun; 130(12):2903-11. PubMed ID: 21796630
[TBL] [Abstract][Full Text] [Related]
4. Dermatopontin inhibits papillary thyroid cancer cell proliferation through MYC repression.
Guo Y; Li H; Guan H; Ke W; Liang W; Xiao H; Li Y
Mol Cell Endocrinol; 2019 Jan; 480():122-132. PubMed ID: 30391671
[TBL] [Abstract][Full Text] [Related]
5. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.
Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
[TBL] [Abstract][Full Text] [Related]
6. Dermatopontin is expressed in human liver and is downregulated in hepatocellular carcinoma.
Li X; Feng P; Ou J; Luo Z; Dai P; Wei D; Zhang C
Biochemistry (Mosc); 2009 Sep; 74(9):979-85. PubMed ID: 19916908
[TBL] [Abstract][Full Text] [Related]
7. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
[No Abstract] [Full Text] [Related]
8. Long non‑coding RNA FOXD2‑AS1/miR‑150‑5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis.
Jiang M; Qiu N; Xia H; Liang H; Li H; Ao X
Int J Oncol; 2019 Mar; 54(3):1043-1052. PubMed ID: 30628646
[TBL] [Abstract][Full Text] [Related]
9. A high level of the long non-coding RNA
She Q; Chen Y; Liu H; Tan J; Li Y
Bioengineered; 2022 May; 13(5):13437-13451. PubMed ID: 36700469
[TBL] [Abstract][Full Text] [Related]
10. Role of dermatopontin in re-epithelialization: implications on keratinocyte migration and proliferation.
Krishnaswamy VR; Korrapati PS
Sci Rep; 2014 Dec; 4():7385. PubMed ID: 25486882
[TBL] [Abstract][Full Text] [Related]
11. Dermatopontin is a novel regulator of the CdCl2-induced decrease in claudin-11 expression.
Yang Q; Hao J; Chen M; Li G
Toxicol In Vitro; 2014 Sep; 28(6):1158-64. PubMed ID: 24909373
[TBL] [Abstract][Full Text] [Related]
12. ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway.
Lin Y; Li C; Xiong W; Fan L; Pan H; Li Y
Cell Death Dis; 2021 Nov; 12(11):1042. PubMed ID: 34725332
[TBL] [Abstract][Full Text] [Related]
13. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
Wang Y; Chen H; Liu W; Yan H; Zhang Y; Cheung AHK; Zhang J; Chen B; Liang L; Zhou Z; Wong CC; Wu WKK; Chan MWY; Cheng ASL; Ma BBY; Yu J; Lo KW; To KF; Kang W
Theranostics; 2022; 12(15):6509-6526. PubMed ID: 36185598
[No Abstract] [Full Text] [Related]
14. Dermatopontin promotes adhesion, spreading and migration of cardiac fibroblasts in vitro.
Liu X; Meng L; Shi Q; Liu S; Cui C; Hu S; Wei Y
Matrix Biol; 2013 Jan; 32(1):23-31. PubMed ID: 23262218
[TBL] [Abstract][Full Text] [Related]
15. Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell Maintenance.
Kramer AC; Blake AL; Taisto ME; Lehrke MJ; Webber BR; Lund TC
Stem Cell Reports; 2017 Sep; 9(3):770-778. PubMed ID: 28844660
[TBL] [Abstract][Full Text] [Related]
16. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
[TBL] [Abstract][Full Text] [Related]
17. Dermatopontin in Skeletal Muscle Extracellular Matrix Regulates Myogenesis.
Kim T; Ahmad K; Shaikh S; Jan AT; Seo MG; Lee EJ; Choi I
Cells; 2019 Apr; 8(4):. PubMed ID: 30970625
[TBL] [Abstract][Full Text] [Related]
18. Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway.
Li D; Hu X; Yu S; Deng S; Yan M; Sun F; Song J; Tang L
Cell Signal; 2020 Sep; 73():109697. PubMed ID: 32593652
[TBL] [Abstract][Full Text] [Related]
19. MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway.
An L; Nie P; Chen M; Tang Y; Zhang H; Guan J; Cao Z; Hou C; Wang W; Zhao Y; Xu H; Jiao S; Zhou Z
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32271880
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cell-derived Extracellular Vesicles Transmitting MicroRNA-34a-5p Suppress Tumorigenesis of Colorectal Cancer Through c-MYC/DNMT3a/PTEN Axis.
Zhao J; Lin H; Huang K
Mol Neurobiol; 2022 Jan; 59(1):47-60. PubMed ID: 34623601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
